학술논문
A three-week regimen of S-1 monotherapy reduced gastrointestinal toxicity and maintained efficacy in patients with gemcitabine-refractory advanced pancreatic cancer
Document Type
Article
Author
Source
In: Japanese Journal of Cancer and Chemotherapy . (Japanese Journal of Cancer and Chemotherapy, 1 March 2015, 42(3):313-317)
Subject
Language
English
ISSN
03850684